000 01571 a2200445 4500
005 20250514010657.0
264 0 _c20011011
008 200110s 0 0 eng d
022 _a0959-8049
024 7 _a10.1016/s0959-8049(01)00196-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBernhard, J
245 0 0 _aResponse shift in the perception of health for utility evaluation. an explorative investigation.
_h[electronic resource]
260 _bEuropean journal of cancer (Oxford, England : 1990)
_cSep 2001
300 _a1729-35 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
650 0 4 _aAdenocarcinoma
_xdrug therapy
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntimetabolites, Antineoplastic
_xtherapeutic use
650 0 4 _aAttitude to Health
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aColonic Neoplasms
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xtherapeutic use
650 0 4 _aHealth Status Indicators
650 0 4 _aHumans
650 0 4 _aLevamisole
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPostoperative Period
650 0 4 _aQuality of Life
650 0 4 _aSwitzerland
700 1 _aLowy, A
700 1 _aMaibach, R
700 1 _aHürny, C
773 0 _tEuropean journal of cancer (Oxford, England : 1990)
_gvol. 37
_gno. 14
_gp. 1729-35
856 4 0 _uhttps://doi.org/10.1016/s0959-8049(01)00196-4
_zAvailable from publisher's website
999 _c11472066
_d11472066